CLINICAL_TRIALS
trial_result
· 2015-12-07
Clinical Trial Update: Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML) [Phase 1]
Summary
A Phase 1 study of KX2-391 in elderly patients with acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kinex Pharmaceuticals Inc. | Conditions: Acute Myelogenous Leukemia | Phase 1 | Status: COMPLETED